A week after an announcement made by Biden's office about former US President's undergoing medical care, Joe Biden rang a ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...

Discover how rectal spacers revolutionize prostate cancer treatment by reducing side effects and enhancing radiation dose ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.